| State the rationale for the use of TMS in depression, anxiety disorders, schizophrenia, and other off-label conditions |
|
|
|
|
|
| Explain regulatory issues and policies concerning TMS |
|
|
|
|
|
| Name the two main components of transcranial magnetic stimulation devices |
|
|
|
|
|
| Operate the TMS device and correctly use it to determine the optimal site and motor threshold |
|
|
|
|
|
| Describe the findings from TMS research in imaging and motor cortex excitability studies |
|
|
|
|
|
| Apply the indications for use of TMS in depression |
|
|
|
|
|
| Identify the risks and side effects of TMS and describe how to conduct a safety screening |
|
|
|
|
|
| Design a protocol for seizure management during TMS administration |
|
|
|
|
|
| Outline steps necessary to set up a TMS service/lab |
|
|
|
|
|